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Letter of correspondence: 
We read the Article by David Engelman and colleagues with interest. Their overview of the key 
operational research questions provides a clear research agenda for the years to come.1 Mass drug 
administration (MDA) using ivermectin reduced the prevalence of both scabies and impetigo 
tremendously in Fiji with a sustained effect even 24 months after the intervention.2 Priority future 
studies are suggested to include non-island populations. 
Outbreaks of scabies occur in refugee camps and centers worldwide. We want to emphasize the 
need for evidence supporting MDA to prevent and treat outbreaks among refugees. Scabies burden 
is high among refugees with an increased rate of complications, including secondary infections.3 
Standard care based on topical permethrin of persons with scabies and their contacts is unlikely to 
contain outbreaks if based on passive case detection considering the limited access to health care 
amongst refugees. In high-income countries, ivermectin-based MDA could be integrated into 
screening programs and may contribute to the reciprocity of the overall program by immediately 
relieving suffering.4 Retrospective data provides limited evidence supporting ivermectin-based MDA 
by early detection and treatment, reducing the number of reinfestations and complications even 
after asylum seekers’  transfer to other centers.5 Prospective data is needed to increase the level of 
evidence,  determine the scabies prevalence justifying MDA  and to decide upon the optimal MDA 
interval, which may depend on  the number of newly arriving refugees. Moxidectin or slow-release 
ivermectin may provide added value in this setting to control scabies.  
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